Filing Details

Accession Number:
0001225208-10-020912
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2010-09-15 20:12:44
Reporting Period:
2010-09-10
Filing Date:
2010-09-15
Accepted Time:
2010-09-15 20:12:44
Original Submission Date:
2010-09-13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
14272 Bristol Myers Squibb Co BMY Pharmaceutical Preparations (2834) 220790350
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1346102 E John Celentano 345 Park Avenue
New York NY 10154
Svp Hr Public Affairs & Philan No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.10 Par Value Disposition 2010-09-10 38,425 $26.99 222,996 No 4 S Direct
Common Stock, $0.10 Par Value Disposition 2010-09-10 39,050 $26.99 183,946 No 4 S Direct
Common Stock, $0.10 Par Value Disposition 2010-09-10 46,975 $26.99 136,971 No 4 S Direct
Common Stock, $0.10 Par Value Disposition 2010-09-10 55,750 $26.99 81,221 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $0.10 Par Value Executive Option (right to buy) Disposition 2010-09-10 52,297 $26.99 52,297 $22.14
Common Stock, $0.10 Par Value Executive Option (right to buy) Disposition 2010-09-10 42,200 $26.99 42,200 $22.73
Common Stock, $0.10 Par Value Executive Option (right to buy) Disposition 2010-09-10 58,333 $26.99 58,333 $24.74
Common Stock, $0.10 Par Value Option (right to buy) Disposition 2010-09-10 42,500 $26.99 42,500 $23.14
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
52,297 2018-03-03 No 4 M Direct
0 2016-03-06 No 4 M Direct
116,667 2016-11-30 No 4 M Direct
0 2004-03-04 2013-03-03 No 4 M Direct
Footnotes
  1. This Form 4 is being amended to report the correct price for these transactions.
  2. Shares used to cover cost of exercise price, taxes, and commisions.
  3. Currently Exercisable.